Get E&O weekly. | Subscribe
Digital health research from Brian Dolan.
Welcome to E&O.
Last week I wrote about two UnitedHealth acquisitions, Bristol Myers Squibb's DTx timeline, and UHG's multiple mulligans in digital diabetes. Here's what's happening this week:
- HHS re-re-confirmed yesterday that we are still in a public health emergency because of COVID--19, and this third declaration will also stay in effect for at least yet another 90 days.
- Bristol Myers Squibb emailed me last week after the newsletter went out. They asked me to remove the launch timeline for their multiple myeloma digital therapeutic. I found that timeline (Q3 2020 launch) on a (somewhat) blinded job posting for the project, while similar job postings explicitly from BMS didn't provide as many details. BMS said their recruiting firm made a mistake and posted an inaccurate timeline, but wouldn't share the